NCT02200055 Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need Status COMPLETED Phase NA
NCT02191761 Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02190071 Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer Status COMPLETED Phase N/A
NCT02159248 Tolfenamic Acid, Gemcitabine and Radiation for Locally Advanced or Metastatic Pancreatic Cancer Requiring Radiation Status WITHDRAWN Phase PHASE1
NCT02155088 BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02154737 Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02138383 Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02132403 (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT02132325 Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung Cancer Status COMPLETED Phase NA
NCT02131493 S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02118077 Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT02117895 Left Celiac Plexus Resection for Pancreatic Cancer at the Body and Tail Status UNKNOWN Phase PHASE3
NCT02117479 Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1) Status TERMINATED Phase PHASE3
NCT02116322 Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study Status TERMINATED Phase NA
NCT02106884 Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel Status COMPLETED Phase PHASE2
NCT02106871 Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer Status WITHDRAWN Phase PHASE1
NCT02098291 An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma Status COMPLETED Phase PHASE2
NCT02098239 Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. Status COMPLETED Phase PHASE2